Back to results
US 2026/0207556 A1Published application
Compounds useful as kinase inhibitors
AssigneeLoxo Oncology, Inc.
InventorNicolas GUISOT
Life of this patent
Estimating the term…
Abstract
This invention relates to novel compounds. The compounds of the invention are tyrosine kinase inhibitors. Specifically, the compounds of the invention are useful as inhibitors of Bruton's tyrosine kinase (BTK). The invention also contemplates the use of the compounds for treating conditions treatable by the inhibition of Bruton's tyrosine kinase, for example cancer, lymphoma, leukemia and immunological diseases.
Claims6
A compound of formula:
- wherein * indicates a chiral center.
A compound of formula:
A compound of formula:
A pharmaceutical composition comprising a compound of formula:
- wherein * indicates a chiral center, and pharmaceutically acceptable excipients.
Dependencies are inferred from the claim text.